A file image is used only for representation purposes. | Photo credit: Reuters
The annual exports of drugs and pharmaceuticals of India touched a record of $ 30 billion for the first time in FY25 reinforced by an annual increase of 31% in March.
At $ 30467.32 million, exports were 9.39% higher than the $ 27851,70 million registered in the fiscal year24, they showed the official commercial data published recently.
Pharmaceutical exports touched $ 30 billion for the first time. The objective of fiscal year 2015 was $ 29.38 billion, said Raja Bhanu, general director of the Pharmaceutical Export Promotion Council, Raja Bhanu.
March performance
The March performance stood out in a prosecutor who will be remembered for developments in the United States market, even when India continued with efforts to take advantage and take advantage of the initial profits of the new markets. If the shortage of generic prescription medications in the United States increased hopes in the fiscal year, towards the end of the year, the reciprocal president of 26% of the rate, Donald Trump, threatened to introduce, had a fight to send more. Pharma, however, did not appear on the list of goods for which the tax was announced and suspended for 90 days.
Pharmaceutical exports in March increased 31.21% year -on -year to $ 3681.51 million ($ 2805.71 million). The next best action that the prosecutor occurred in January when exports increased 21.47% to $ 2590.88 million ($ 2132.92 million). May was the other month when growth touched two digits (10.63% at $ 2305.56 million), while February was the only month in which it hired 1.52% at $ 2474.22 million).
Beyond the US factor, exports of the fiscal year25 came to geopolitical tensions, economic slowdown and logistics challenges.
Product category
Granular details are expected for March, said Pharmexcil DG. The data for April-FEBRARY show formal medicines and biological as a product category led with $ 2018.18 million and represented more than 75% of total exports. This category expanded in almost 9% year -on -year.
Bulk medications and drug intermediate exports were the following higher, the duration of 11 months, increasing 1.40% to $ 4319.30 million. He thought that the third largest export category, among pharmaceutical products, the value of vaccine exports decreased 4.20% to $ 1043.76 million.
The export of surgical increased 5.16% and the value of exports was $ 683.47 million. Ayush and Herbal Product exports grew 6.17% to $ 620.97 million. Total pharmaceutical exports until February This prosecutor increased 6.95% to $ 26785.69 million.
UE. UU.
The United States is still the largest market for years now maintained its preeminence representation of more than a third of Indian pharmaceutical exports. In terms of value value, the increase in exports to the US, 14.29% to $ 8953.37 million ($ 7833.75 million) was. The United Kingdom, Brazil, France and South Africa were others in the five main countries that counted together for less than 10.5% of exports.
Also read: The US Tariff
South Africa appeared on the list despite export contraction by 1.78%. Duration The 11 months of the prosecutor, the 25 main markets in countries where exports decreased were United Arab Emirates (in 17.70%); Türkiye (16%); Sri Lanka (14.60%); Netherlands (13.79%), China (10.60%) and Belgium (7.37%). The decrease in exports was 3.80% to Mexico and 0.14% to Thailand, according to official data.
The best regions
Regionwise, NAFTA, Europe, Africa and Lac were the four main regions together representing 76% of the pharmaceutical exports of India. NAFTA represented 36.60% with exports that increased 14.06% to $ 9804.78 million.
Among the regions where exports decreased were Africa (1.74%) and the northeast of Asia (4.30%).
Published – April 18, 2025 11:11 PM IST